Healthcare Quality
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply ...
In the U.S. and around the world, quality standards developed by the U.S. Pharmacopeia (USP) support the availability of safe, quality medicines, regulatory efficiencies, and a strong global medicine supply chain.
Ensuring quality COVID-19 vaccine delivery through the ‘last mile’...
The COVID-19 pandemic has presented unprecedented challenges around the world, including to national public health systems and the international biopharmaceutical industry.
Quality medicines and sub-Saharan Africa
Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.
Poor quality medicines and drug resistance
Compendium, compendia, compendial: Clearing up the mystery of these terms...
In conversations about the role of quality standards in public health, you might come across the words “compendia” and “compendial.” At USP, terms like “compendial approaches,” “compendial standards,” and “compendial tools” are part of our everyday vocabulary.
Can changes to prescription labels and other public standards help tame the opioid cr...
The opioid crisis in the U.S. seems to be part of nearly every news broadcast and news site today. And based on the number of people affected by this crisis, serious conversations about how to help are more important than ever.
USP Overview - Empowering a healthy tomorrow
A healthier world needs a strong foundation—one that establishes quality, sets the bar for scientific rigor and technological progress, between industry, nonprofits, government and academia.
Pharmaceutical Continuous Manufacturing Technology and Applications...
USP is exploring how its extensive expertise in developing quality standards for drug products and ingredients can contribute to pharmaceutical continuous manufacturing.